Related Experiment Video
Updated: May 15, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Optimizing statistical parametric mapping analysis of 18F-FDG PET in children.
Frederique Archambaud1, Viviane Bouilleret, Lucie Hertz-Pannier
1Inserm, U663, Service de Neurologie et Métabolisme, Hôpital Necker, 149 rue de Sèvres, Paris, 75015, France. catherine.chiron@nck.aphp.fr.
A new pediatric pseudo-control group significantly improves the specificity of statistical parametric mapping (SPM) analysis for 18F-fluoro-2-deoxy-d-glucose-positron-emission tomography (FDG-PET) in children with epilepsy. This method reduces artifacts and enhances diagnostic accuracy in pediatric neuroimaging.
Area of Science:
- Neuroimaging
- Pediatric Neurology
- Medical Image Analysis
Background:
- Statistical Parametric Mapping (SPM) is an objective tool for analyzing 18F-fluoro-2-deoxy-d-glucose-positron-emission tomography (FDG-PET) images.
- Ethical constraints prevent obtaining control data from healthy children, limiting SPM application in pediatric populations.
- Using adult controls for pediatric FDG-PET analysis presents significant limitations.
Purpose of the Study:
- To develop and validate a pseudo-control group of children for FDG-PET studies in pediatric epilepsy.
- To optimize SPM analysis for pediatric FDG-PET by establishing an age-matched control dataset.
Main Methods:
- Analyzed FDG-PET images from 47 children with refractory focal epilepsy using visual and SPM analysis.
- Compared SPM performance using two control groups: healthy young adults and a pediatric pseudo-control group.
- The pediatric pseudo-control group comprised patients with epilepsy and normal-appearing PET scans (visual and SPM).
Main Results:
- Visual analysis detected hypometabolic areas in 87% of pediatric epilepsy cases.
- The pediatric pseudo-control group significantly improved SPM specificity (97% vs. 89%) and positive predictive value (86% vs. 65%).
- This approach reduced hypometabolic cortical artifacts by 41%, particularly in younger patients.
Conclusions:
- An age-matched pseudo-control group optimizes SPM analysis of FDG-PET in pediatric epilepsy.
- This methodology offers a viable solution for addressing control group limitations in pediatric neuroimaging.
- The approach may be applicable to other pediatric brain pathologies requiring FDG-PET analysis.
More Related Videos
09:03Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
Published on: October 22, 2019
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017